Rona Therapeutics Funding: $200M Raised, Series A+ (2024)
Rona Therapeutics is based in Shanghai, China. It has raised $200M in total funding. Latest round: Series A+.
Rona Therapeutics funding overview
Rona Therapeutics is based in Shanghai, China. Rona Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A+ announced in July 2024. The round record for Rona Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include LongRiver Investments, Lilly Asia Ventures, BioTrack Capital, Zhongqi Capital, Zhaode Investment, CMB International and 3 others. 9 distinct backers are named across the disclosed rounds.
Rona Therapeutics at a glance
Total raised
$200M
Latest round
Series A+
Latest round date
July 2024
Headquarters
Shanghai, China
Notable investors
LongRiver Investments, Lilly Asia Ventures, BioTrack Capital, Zhongqi Capital, Zhaode Investment, CMB International, Platanus, Fontus Capital
Frequently asked about Rona Therapeutics funding
How much has Rona Therapeutics raised?
Rona Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Rona Therapeutics?
LongRiver Investments, Lilly Asia Ventures, BioTrack Capital, Zhongqi Capital, Zhaode Investment, CMB International are named among the investors backing Rona Therapeutics.
What was the latest Rona Therapeutics funding round?
The most recent disclosed round is a Series A+, announced in July 2024.
Where is Rona Therapeutics based?
Rona Therapeutics is based in Shanghai, China.
When did Rona Therapeutics last raise?
The last disclosed Rona Therapeutics round closed in July 2024 at Series A+.
Round data for Rona Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
